The Board on meeting held today on 27th May, 2025 approved the following. 1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report 2. Consolidated Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board, meeting on 27 May 2025, approved standalone and consolidated audited financial results for the quarter and year ended 31 March 2025, along with the auditor's report. Revenue from operations fell to Rs 1,568.12 lakhs (FY25) from Rs 1,693.22 lakhs (FY24), a decline of about 7%. Profit before tax dropped sharply to Rs 18.67 lakhs from Rs 80.70 lakhs, and net profit fell to Rs 15.16 lakhs from Rs 62.11 lakhs. The Explosives division swung to a segment loss of Rs 106.58 lakhs (vs Rs 4.96 lakhs loss in FY24) and was the main drag, while Transportation and Adblue divisions improved year-on-year. The auditor (Ashok R Majethia & Co) issued an unmodified (clean) opinion with no qualifications. The board also appointed M/s Ganesh Palve and Associates as secretarial auditors for 5 years (FY26–FY30) and M/s Ghatiya and Associates as internal auditors for 3 years (FY26–FY28), and updated its Related Party Transaction policy.
Sharp fall in profitability, driven by the Explosives segment turning into a large loss, is a negative signal for shareholders and may pressure the stock. However, the auditor gave a clean opinion, operating cash flow turned positive at Rs 19.18 lakhs (vs negative Rs 20.98 lakhs last year), and cash balances remain healthy at Rs 279.82 lakhs. New auditor appointments and refreshed RPT policy are routine governance positives but unlikely to move the stock materially.